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Objective: Understanding patients’ and physicians’ perceptions of type 2 diabetes mellitus 
(T2DM) management and treatment has important implications for diabetes care, allowing the 
identification of clinical practice issues that could be improved, leading to patients’ better under-
standing of the illness and, consequently, healthier self-management behaviors. The objective 
of this study was to identify differences between physicians’ and T2DM patients’ perceptions 
related to health status, patient-reported outcomes assessments, and T2DM management and 
treatment, in routine clinical practice in Spain.
Methods: This was an observational, cross-sectional study including 1,012 T2DM patients 
and 974 physicians from 47 and 52 Spanish provinces, respectively. An electronic structured 
self-administered questionnaire containing 17 questions was designed aiming to address both 
physicians’ and patient’s perceptions on overall T2DM health status and patient-reported 
outcomes.
Results: T2DM patients perceived a worse health status (40% reported having a “good” and 
38% a “neither good nor bad” health status) compared with physicians’ perceptions (77% 
thought patients had a “good” health status). Most patients answered being “satisfied” or “neither 
satisfied nor unsatisfied” with the given information, while physicians considered that patients 
were “satisfied” or “very satisfied” with the information for self-monitoring blood glucose and 
treatment administration. Fifty-seven percent of patients reported that medical recommenda-
tions were “important”, while 58% of physicians considered it as “very important”. Fifty-three 
percent of patients perceived that their current T2DM treatment suited their preferences “quite 
a lot”, and this was lower than the proportion of physicians (69%) that believed this for their 
patients. Additionally, a lower percentage of patients (53%) than physicians (79%) believed 
that their treatment improved their health-related quality of life “quite a lot”. All differences 
between patients and physicians were statistically significant (P,0.001).
Conclusion: Patients and physicians demonstrate different views concerning all questions 
related to T2DM health status and diabetes management and treatment (information, recom-
mendations, satisfaction, and preferences).
Keywords: T2DM, PROs, health-related quality of life, HRQoL, preferences, adherence, 
treatment satisfaction, perception
Introduction
Worldwide, the 2013 prevalence of diabetes mellitus (DM) was estimated at 8.3%, 
affecting 387 million people and producing 5.1 million deaths.1 This prevalence is 
expected to increase up to 439 million adults by 2030.2 In Spain, DM prevalence among 
adults is 13.8% (95% confidence interval: 10; 15), with up to 6% of the population 
remaining underdiagnosed3 and having a mortality risk up to three times greater than 
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the general population.4 Type 2 DM (T2DM) accounts for 
85%–95% of all diabetes in developed countries,1 and it is 
associated with a two to four times greater probability of 
cardiovascular disease than in the general population, as well 
as an increased mortality risk.5,6
It is widely recognized that an appropriate management of 
hyperglycemia can lead to an achievement of optimal diabetes 
control, thereby reducing the risk of cardiovascular events by 
approximately 50%.7 However, the micro- and macrovascular 
complications associated with long-term disease continue 
to be the main factor for the social and economic burden of 
T2DM.8 In addition to clinical and economic aspects, T2DM 
may have a direct influence on daily personal, family, social, 
and working life, affecting patients’ functional capacity and 
health-related quality of life (HRQoL).9
Therefore, T2DM is considered a complex chronic 
disease, which requires continuous medical care with 
multifactorial risk reduction strategies beyond glycemic 
control.10 In addition, the successful management of dia-
betes should include the active behavioral involvement of 
patients. Patients diagnosed with T2DM need to implement 
certain habits that require self-commitment and responsibility 
(eg, blood glucose monitoring in diabetes; adherence to medi-
cation, etc).11,12 For this purpose, patient education regarding 
glucose monitoring, injection techniques, and lifestyle inter-
ventions, focusing on diet and on the importance of physical 
activity, should be integrated into the treatment program. 
The involvement of patients is crucial for the management 
of T2DM, for the prevention of acute complications, and for 
the reduction of long-term complications.10,13 In Spain, where 
T2DM patients are mainly managed in the primary care (PC) 
setting,14 a patient–physician partnership is key to achieving 
optimal treatment results and to improving patients’ empow-
erment and disease management.11
Moreover, patients’ involvement in decision making 
may improve adherence to therapy.13 When patients feel that 
their disease perspective and experience (patient-reported 
outcomes [PROs]) are taken into account by PC physicians, 
they increase their medication adherence and cooperate 
more actively with lifestyle recommendations, improving 
personal satisfaction, clinical results,11 and overall quality 
of care.15 In this study, it is proposed that the knowledge 
from both patients’ and health care professionals’ perspec-
tives and experience in real-life clinical practice may have 
important implications for diabetes care. Recognizing such 
information allows the identification of practice issues that 
could be improved or the potential introduction of changes 
in health care plans.16 Nevertheless, it has been difficult to 
find in the literature studies that elicit patient self-perceived 
HRQoL added to their perception of PROs assessment, and 
that compare patients’ perceptions and beliefs with those of 
PC physicians.
Therefore, to the authors’ knowledge, this is the first 
study specifically designed to identify differences between 
physicians’ and T2DM patients’ perceptions regarding health 
status, PROs evaluation, and T2DM management and treat-
ment, from the Spanish National Healthcare System (NHS) 
perspective.
Research design and methods
An observational, cross-sectional study was performed. 
The study protocol was approved by the Clinical Research 
Ethics Committee of the Hospital Universitario Puerta de 
Hierro (Majadahonda, Madrid). All participants in the study 
received information and gave their consent to participate 
prior to their inclusion in the study.
Participants
Sample size estimation was calculated based on the 2013 
Spanish adult population (34,581,569),17 published data 
on the prevalence of T2DM patients (10%–15%),3 and the 
number of PC physicians practicing in the Spanish NHS 
(28,675).18 Applying the maximum variability standard 
criteria with a 99% confidence level and 4% precision for 
both groups, the sample size required was estimated at 1,012 
T2DM patients and 974 PC physicians.
Patients
Eligible participants were T2DM patients at least 18 years old 
who were able to adequately answer the study questions. Patient 
selection was carried out with the support of a FEDE (Fed-
eración de Diabéticos Españoles [Spanish Diabetic Patients 
Federation]). Members of the different societies belonging to 
the FEDE from 52 Spanish provinces were invited to partici-
pate. The recruitment process was conducted from February to 
June 2014, until the desired sample size was achieved.
Physicians
PC physicians from 52 Spanish provinces were randomly 
selected and invited to take part in the study in collabora-
tion with the Spanish Physician Association RedGDPs (Red 
de Grupos de Estudio de la Diabetes en Atención Primaria 
de la Salud). Physicians were eligible to participate if they 
practiced in the Spanish public National Health care System 
(NHS) and if they had been practicing their profession for at 
least 5 years post-training residency. The recruitment process 
was also conducted from February to June 2014, until the 
desired sample size was achieved.
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survey design
An ad hoc electronic self-administered questionnaire con-
taining 17 questions was developed for both patients and 
physicians, respectively, based on the information obtained 
from a literature review. The survey was structured in three 
parts: 1) two questions about the current health status of 
T2DM patients; 2) five questions related to PROs evaluation 
in T2DM (HRQoL and treatment persistence, adherence, sat-
isfaction, and preferences); and 3) ten questions about T2DM 
management and treatment. All questions were rated using 
a five-point Likert scale (Table 1). In all cases, the answers 
corresponded to the self-perception of T2DM patients and 
the perception of physicians about their T2DM population, 
respectively. In order to facilitate patients’ participation, 
they could also answer the questionnaire by phone in case 
of unavailability of Internet access.
study variables
Sociodemographic variables were collected for both popula-
tions. Specifically, for T2DM patients, the variables collected 
were age, sex, place of residence, educational level, and 
employment status. Moreover, patients informed about the 
following clinical variables: time since T2DM diagnosis, 
treatment type (oral, injected, combined therapy), and 
comorbidities (hypertension, hypercholesterolemia, and obe-
sity) and their treatment. Physicians reported the following 
variables: age, sex, health care center area, and approximate 
number of T2DM patients attending per month.
Analysis
A descriptive analysis was performed including all participants 
with completed responses. Absolute and relative frequencies 
were calculated for qualitative variables. Measurements of 
central tendency and dispersion were reported for quantitative 
variables. Scores distribution obtained for each question was 
compared between groups applying the chi-square test. For 
all statistical tests, P,0.05 was considered significant. SPSS 
version 19.0 was used for data analysis.
Results
Description of the participants
Of the 6,747 patients who were invited to participate in 
the survey, a total of 1,012 (15%) T2DM patients from 
47 different Spanish provinces participated in the study. 
On the other hand, of the 1,021 PC physicians invited to 
participate in the survey, a total of 974 (95.4%) responded to 
Table 1 Ad-hoc self administered survey used in the study
Assessed aspects Questions (five-point Likert scale)
1. health status  1. Patient current health statusa
 2. how much does the T2DM affect your current health statusb
2.  PrOs: hrQol and treatment persistence,  
adherence, satisfaction, and preferences
 3. Frequency of PrOs evaluation by physiciansc
 4. importance given to the PrOs evaluation by physiciansd
 5. Frequency of changes in T2DM treatment to improve PrOsc
 6. Frequency of changes in T2DM treatment to suit patient preferencesc
 7. Physician–patient relationshipe
3. Diabetes management and treatment  8.  Frequency with which nurses provide information about T2DM, sMBg, and treatment 
administration techniques (oral or injectable)f
 9.  Patient satisfaction with the information provided by nurses about T2DM, sMBg, and treatment 
administration techniques (oral or injectable)g
10.  Frequency with which patients follow physicians’ recommendations about routine sMBg, 
routine medical visits, diet, exercise, oral treatment, and injectable treatmentf
11.  Patient satisfaction with physicians’ recommendations about routine sMBg, routine medical 
visits, diet, exercise, oral treatment, and injectable treatmentg
12.  The extent to which physicians’ recommendations about routine sMBg, routine medical visits, 
diet, exercise, oral treatment, and injectable treatment allow T2DM controlb
13. importance given to the physicians’ recommendationsd
14. Frequency with which comorbidities are considered by physicians when deciding the T2DM treatmentf
15. The extent to which T2DM treatment suits patient preferencesb
16. The extent to which T2DM treatment improves patient hrQolb
17.  importance of new technologies (PDAs, cell phone applications, online information, etc) for 
diabetes self-managementb
Notes: Five-point likert scale: aVery bad/Bad/neither good nor bad/good/Very good; bnot at all/A little/neither too much nor too little/Quite a lot/A lot; cnever/Almost 
never/sometimes/Often/Very often; dnot at all important/somewhat important/neither important nor unimportant/important/Very important; eVery bad/Bad/Poor/good/
Very good; fnever/Almost never/sometimes/Frequently/Always; gNot at all satisfied/Somewhat unsatisfied/Neither satisfied nor unsatisfied/Satisfied/Very satisfied.
Abbreviations: hrQol, health-related quality of life; PDAs, personal digital assistants; PrOs, patient-reported outcomes; sMBg, self-management of blood glucose; 
T2DM, type 2 diabetes mellitus.
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the questionnaires, distributed among 52 Spanish provinces. 
The final sample for this analysis was therefore composed of 
1,012 patients and 974 independent physicians, being 1.04 
patients included in the study per physician.
The patients’ mean age was 54.2 (standard deviation 
[SD]: 11.2) years, and approximately half of the studied 
subjects were males (51%). Only 26% (n=266) of participants 
had college education and 44% (n=445) were retired at the 
time of the study. The mean time since T2DM diagnosis 
was 11.3 (SD: 9.7) years. Ninety percent of patients (n=917) 
received prescribed medication for their diabetes (51.2% 
[n=518] were treated with oral medication only, 15.3% 
[n=155] with injectable treatment alone, and 24.1% [n=244] 
received both oral and injected medications).
Participant physicians had a mean age of 52.4 (SD: 7.8) 
years, being 66.3% (n=646) male. Overall, 39% (n=380) of 
physicians reported seeing one to 50 T2DM patients per month, 
36% (n=351) indicated 51 to 100, and 25% (n=243) estimated 
more than 100 visits per month. Patients’ and physicians’ socio-
demographic and clinical variables are described in Table 2.
Table 2 sociodemographic and clinical characteristics of the T2DM patients and physicians
Characteristics T2DM patients n=1,012 Physicians n=974
Age (years), mean (SD) 54.2 (11.2) 52.4 (7.8)
Male, n (%) 519 (51) 646 (66.3)
Place of residence, n (%)
rural (,5,000 inhabitants)
semi-urban (5,000–19,999 inhabitants)
Urban ($20,000 inhabitants)
99 (10)
223 (22)
690 (68)
182 (19)
252 (26)
540 (55)
Educational level, n (%)
no education
Primary school
high school
Job training
college studies (undergraduate)
college studies (graduate)
93 (9)
275 (27)
220 (22)
158 (16)
226 (22)
40 (4)
–
–
–
–
–
–
Employment status, n (%)
Worker
Freelance
incapacity
student
Unemployed
retired
housework
Other
289 (29)
64 (6)
20 (2)
4 (0.4)
83 (8)
445 (44)
105 (10)
2 (0.2)
–
–
–
–
–
–
–
–
Time from diagnosis (years), mean (SD) 11.3 (9.7) –
Time duration (years), mean (SD) 10.7 (9.6) –
Administration route, n (%)
Oral
injectable
762 (75)
400 (40)
–
–
Comorbidities, n (%)
hypertension
Diagnosis
Pharmacological treatment
hypercholesterolemia
Diagnosis
Pharmacological treatment
hypertriglyceridemia
Diagnosis
Pharmacological treatment
Obesity
Diagnosis
Pharmacological Treatment
482 (48)
424 (42)
663 (66)
378 (37)
515 (51)
164 (16)
411 (41)
56 (6)
–
–
–
–
–
–
–
–
Medical specialty, n (%)
Primary care
Other
–
–
959 (98.5)
15 (1.5)
T2DM patients visited per month, mean (SD) – 91 (74)
Abbreviations: T2DM, type 2 diabetes mellitus; sD, standard deviation.
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Questionnaire scores
Statistically significant differences between patients’ and 
physicians’ scores were found in all the included questions 
(P,0.001).
health status questions
The questionnaire scores showed that T2DM patients per-
ceived a worse health status compared with physicians’ 
perceptions. Seventy-seven percent of physicians answered 
that their patients had a “good” health status, while most 
patients considered their health status was “good” (40%) or 
“neither good nor bad” (38%).
On the other hand, patients thought that T2DM had a 
lower impact on their current health status compared with 
physicians, since most patients answered that T2DM affected 
their health status “neither too much nor too little” (38%), 
while 74% of physicians thought that T2DM affected patients’ 
health status “a lot”.
PrOs questions
Table 3 reflects the relative importance given by both patients 
and physicians to PROs assessment (HRQoL and treatment 
persistence, adherence, satisfaction, and preferences) and 
the relative importance given by physicians to the impact of 
PROs on T2DM treatment and management.
In general, most patients reported that their doctors 
assessed PROs “sometimes” or “often”. However, physicians 
mainly indicated that they “often” or “very often” asked their 
Table 3 PrOs questions*
Frequency of PROs evaluation by Phy, % (95% CI)
Group Never Almost never Sometimes Often Very often
hrQol Pat (n=1,012) 7 (5; 8) 11 (9; 13) 28 (25; 30) 40 (37; 43) 15 (13; 17)
Phy (n=974) 0 (0; 1) 2 (1; 3) 21 (19; 24) 61 (58; 65) 15 (13; 17)
Treatment 
preferences
Pat (n=1,012) 14 (11; 16) 15 (13; 18) 30 (27; 33) 31 (28; 34) 10 (8; 12)
Phy (n=974) 0 (0; 1) 2 (1; 3) 18 (16; 21) 63 (60; 66) 17 (15; 19)
Treatment 
persistence
Pat (n=1,012) 7 (6; 9) 7 (6; 9) 24 (22; 27) 43 (40; 46) 18 (16; 21)
Phy (n=974) 0 (0; 0) 0 (0; 3) 8 (6; 10) 56 (53; 59) 36 (33; 39)
Treatment 
adherence
Pat (n=1,012) 7 (5; 8) 9 (7; 11) 25 (23; 28) 42 (39; 45) 17 (15; 20)
Phy (n=974) 0 (0; 0) 0 (0; 0) 6 (4; 7) 49 (45; 52) 46 (43; 49)
Treatment 
satisfaction
Pat (n=1,012) 9 (8; 11) 10 (8; 12) 28 (26; 31) 39 (36; 42) 13 (11; 16)
Phy (n=974) 0 (0; 0) 2 (1; 3) 17 (14; 19) 59 (55; 61) 23 (21; 26)
Importance given to the PROs evaluation by Phy, % (95% CI)
Group Not at all  
important
Somewhat  
important
Neither important  
nor unimportant
Important Very important
hrQol Pat (n=1,012) 1 (1; 2) 3 (2; 3) 16 (13; 18) 47 (44; 50) 34 (31; 40)
Phy (n=974) 0 (0; 0) 0 (0; 1) 1 (1; 2) 52 (49; 55) 47 (43; 50)
Treatment 
preferences
Pat (n=1,012) 2 (1; 2) 4 (3; 5) 21 (18; 23) 52 (49; 55) 22 (19; 24)
Phy (n=974) 0 (0; 0) 1 (1; 2) 12 (10; 14) 67 (64; 70) 20 (17; 22)
Treatment 
persistence
Pat (n=1,012) 1 (1; 2) 4 (3; 6) 18 (15; 20) 51 (48; 54) 26 (23; 29)
Phy (n=974) 0 (0; 0) 0 (0; 0) 2 (1; 3) 50 (47; 53) 48 (45; 51)
Treatment 
adherence
Pat (n=1,012) 2 (1; 3) 3 (2; 4) 17 (15; 20) 53 (50; 56) 25 (22; 27)
Phy (n=974) 0 (0; 0) 0 (0; 1) 1 (0; 1) 36 (33; 39) 63 (60; 66)
Treatment 
satisfaction
Pat (n=1,012) 1 (1; 2) 4 (2; 5) 17 (15; 19) 52 (49; 55) 26 (23; 29)
Phy (n=974) 0 (0; 0) 0 (0; 1) 5 (4; 6) 57 (54; 60) 38 (35; 41)
Frequency of changes in T2DM treatment to improve PROs, % (95% CI)
Group Never Almost never Sometimes Often Very often
hrQol Pat (n=1,012) 12 (10; 14) 15 (13; 17) 35 (32; 38) 26 (23; 29) 13 (11; 15)
Phy (n=974) 0 (0; 1) 4 (3; 5) 40 (37; 43) 47 (44; 50) 9 (7; 11)
Treatment 
persistence
Pat (n=1,012) 15 (13; 17) 17 (15; 20) 31 (29; 34) 25 (23; 28) 11 (9; 13)
Phy (n=974) 0 (0; 0) 3 (2; 4) 33 (30; 36) 51 (48; 54) 13 (11; 15)
Treatment 
adherence
Pat (n=1,012) 15 (13; 17) 16 (13; 18) 33 (30; 36) 25 (22; 28) 11 (9; 13)
Phy (n=974) 0 (0; 0) 3 (2; 4) 24 (21; 27) 51 (48; 54) 22 (19; 24)
Treatment 
satisfaction
Pat (n=1,012) 14 (12; 16) 19 (17; 22) 33 (30; 36) 24 (21; 26) 10 (8; 12)
Phy (n=974) 0 (0; 1) 4 (3; 6) 32 (29; 35) 50 (46; 53) 13 (11; 16)
Note: *P,0.001 in all comparisons.
Abbreviations: CI, confidence interval; HRQoL, health-related quality of life; Pat, patients; Phy, physicians; PROs, patient-reported outcomes; T2DM, type 2 diabetes 
mellitus.
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patients about PROs. The estimated percentage of patients 
responding that physicians evaluated their treatment per-
sistence “very often” was 18%, compared to the 36% of 
physicians who considered they assessed patients’ treatment 
persistence “very often”. Interestingly, almost half of the 
physicians (46%) thought they assessed treatment adherence 
“very often”, while only 17% of patients agreed with this 
statement.
Added to this, both patients and physicians agreed on the 
importance of PROs for T2DM management; nevertheless, 
the proportion of physicians who considered their assessment 
“important” or “very important” was statistically significantly 
higher for all comparisons. As an example, most physicians 
(63%) answered that treatment adherence was very important 
in order to achieve optimal clinical outcomes, while only 25% 
of patients considered this attribute of great importance for 
doctors. Moreover, 51% of the physicians included reported 
that they “often” changed treatment, aiming at improving 
treatment adherence, while only a quarter of patients (25%) 
perceived that physicians changed treatment to improve their 
medication adherence.
In general, the majority of physicians reported that they 
“often” changed treatment in order to improve PROs, while 
most patients perceived that physicians only changed treat-
ments “sometimes” in order to improve their PROs. Finally, 
although most participants answered that the patient–physician 
relationship was “good”, while more physicians had a similar 
opinion about it (68%) compared with patients (53%).
T2DM management and treatment questions
information provided
Regarding the information about treatment techniques and 
self-management provided to patients by nurses, the results in 
Table 4 show that the majority of patients answered that they 
received information about T2DM, self-monitoring of blood 
glucose (SMBG), and treatment administration techniques 
from nurses “sometimes” or “frequently”, whereas physi-
cians indicated that this information was given “frequently” 
or “always” to the patients. A high percentage of physicians 
perceived that nurses “always” assessed patients’ abilities 
to check blood glucose levels (38%) or trained them how 
to administrate their treatments (40%), compared to 14% of 
patients who answered that they were “always” taught how to 
perform SMBG or received information regarding treatment 
dosage and administration (13%).
In addition, most patients answered that they were 
“satisfied” or “neither satisfied nor unsatisfied” with the 
given information; however, patients’ satisfaction was higher 
according to physicians, who considered that patients were 
“satisfied” or “very satisfied” with the information for SMBG 
and treatment administration.
recommendations
Table 5 reports the frequency with which patients followed 
physicians’ recommendations about routine SMBG or medi-
cal visits, diet, exercise, and oral treatments and the degree 
of satisfaction with these recommendations.
Table 4 T2DM management and treatment questions*
Frequency with which nurses provide information about the following topics, % (95% CI)
Group Never Almost never Sometimes Frequently Always
T2DM Pat (n=1,012) 13 (11; 15) 13 (11; 15) 30 (27; 32 ) 29 (27; 32) 15 (13; 17)
Phy (n=974) 0 (0; 1) 4 (3; 6) 19 (17; 22) 48 (44; 51) 29 (26; 32)
sMBg Pat (n=1,012) 15 (13; 17) 13 (11; 15) 30 (27; 33) 32 (29; 35) 14 (12; 17)
Phy (n=974) 1 (0; 1) 2 (1; 3) 11 (9; 13) 49 (46; 52) 38 (34; 41)
Treatment  
administration 
techniques
Pat (n=1,012) 21 (19; 24) 14 (12; 16) 29 (26; 32) 27 (25; 30) 13 (11; 15)
Phy (n=974) 1 (0; 1) 2 (1.1; 3) 14 (12; 16) 43 (40; 46) 40 (37; 43)
Patient satisfaction with the information provided by nurses about the following topics, % (95% CI)
Group Not at all  
satisfied
Somewhat  
unsatisfied
Neither satisfied  
nor unsatisfied
Satisfied Very satisfied
T2DM Pat (n=1,012) 4 (3; 6) 7 (5; 8) 24 (22; 27) 47 (44; 50) 18 (16; 20)
Phy (n=974) 1 (0; 2) 4 (3; 5) 19 (16; 21) 60 (57; 63) 16 (14; 19)
sMBg Pat (n=1,012) 5 (4; 6) 6 (5; 7) 24 (21; 16) 48 (45; 51) 18 (15; 20)
Phy (n=974) 0 (0; 1) 3 (2; 3) 11 (9; 13) 61 (58; 64) 25 (22; 27)
Treatment  
administration 
techniques
Pat (n=1,012) 6 (5; 7) 5 (4; 7) 29 (26; 32) 43 (40; 46) 17 (14; 19)
Phy (n=974) 0 (0; 1) 3 (2; 4) 12 (10; 14) 60 (57; 63) 25 (23; 28)
Note: *P,0.001 in all comparisons.
Abbreviations: CI, confidence interval; Pat, patients; Phy, physicians; SMBG, self-management of blood glucose; T2DM, type 2 diabetes mellitus.
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Table 5 Physician recommendations*
Frequency with which patients follow physicians’ recommendations about the following topics, % (95% CI)
Group Never Almost never Sometimes Frequently Always
routine sMBg Pat (n=1,012) 2 (1; 2) 3 (2; 4) 19 (17; 21) 41 (38; 44) 36 (33; 39)
Phy (n=974) 0 (0; 0) 1 (0; 1) 24 (21; 27) 65 (61; 67) 11 (9; 13)
routine medical visits Pat (n=1,012) 1 (0; 2) 4 (3; 5) 17 (14; 19) 37 (34; 40) 41 (38; 44)
Phy (n=974) 0 (0; 0) 0 (0; 0) 14 (12; 17) 72 (69; 75) 14 (12; 16)
Diet Pat (n=1,012) 2 (1; 3) 5 (4; 7) 25 (22; 28) 45 (42; 48) 23 (20; 25)
Phy (n=974) 0 (0; 1) 15 (12; 17) 59 (56; 62) 23 (21; 26) 3 (2; 4)
exercise Pat (n=1,012) 5 (4; 6) 12 (10; 14) 28 (25; 31) 35 (32; 38) 20 (17; 22)
Phy (n=974) 0 (0; 1) 19 (17; 22) 59 (56; 62) 19 (17; 22) 2 (1; 3)
Oral treatment Pat (n=1,012) 9 (7; 11) 2 (1; 3) 11 (9; 13) 31 (28; 34) 47 (44; 50)
Phy (n=974) 0 (0; 0) 0 (0; 0) 4 (3; 5) 72 (69; 75) 24 (21; 26)
injectable treatment Pat (n=1,012) 34 (31; 37) 3 (2; 5) 11 (9; 13) 23 (20; 26) 29 (27; 32)
Phy (n=974) 0 (0; 0) 1 (0; 2) 9 (7; 11) 54 (51; 57) 36 (33; 39)
Patient satisfaction with physicians’ recommendations about the following topics, % (95% CI)
Group Not at all  
satisfied
Somewhat  
unsatisfied
Neither satisfied  
nor unsatisfied
Satisfied Very satisfied
routine sMBg Pat (n=1,012) 1 (1; 2) 3 (2; 4) 18 (16; 20) 53 (49; 56) 25 (22; 28)
Phy (n=974) 0 (0; 0) 3 (2; 4) 17 (15; 20) 71 (68; 74) 9 (7; 11)
routine medical visits Pat (n=1,012) 1 (0; 1) 4 (2; 5) 17 (15; 19) 54 (51; 57) 25 (22; 27)
Phy (n=974) 0 (0; 0) 1 (0; 1) 10 (8; 12) 76 (73; 79) 14 (12; 16)
Diet Pat (n=1,012) 2 (1; 2) 7 (5; 8) 26 (24; 29) 49 (46; 52) 17 (14; 19)
Phy (n=974) 1 (0; 1) 14 (12; 17) 42 (39; 45) 39 (36; 42) 5 (3; 6)
exercise Pat (n=1,012) 2 (1; 3) 7 (6; 9) 28 (25; 31) 45 (42; 48) 17 (15; 20)
Pat (n=1,012) 1 (0; 1) 15 (12; 17) 43 (40; 47) 37 (34; 40) 4 (3; 6)
Oral treatment Phy (n=974) 4 (2; 5) 4 (3; 5) 19 (17; 22) 50 (47; 53) 24 (21; 26)
Pat (n=1,012) 0 (0; 0) 0 (0; 1) 9 (8; 11) 74 (71; 77) 16 (14; 18)
injectable treatment Phy (n=974) 11 (9; 13) 3 (2; 4) 33 (30; 36) 37 (34; 34) 16 (13; 18)
Pat (n=1,012) 0 (0; 1) 9 (7; 11) 21 (18; 23) 59 (56; 62) 11 (9; 13)
The extent to which physicians’ recommendations allow T2DM control, % (95% CI)
Group Not at all A little Neither too much  
nor too little
Quite a lot A lot
routine sMBg Pat (n=1,012) 2 (1; 2) 2 (1; 3) 19 (16; 21) 55 (52; 58) 23 (20; 25)
Phy (n=974) 0 (0; 1) 5 (3; 6) 19 (16; 21) 67 (64; 70) 9 (8; 11)
routine medical visits Pat (n=1,012) 1 (0; 2) 4 (3; 5) 23 (20; 25) 53 (50; 56) 19 (17; 22)
Phy (n=974) 0 (0; 0) 1 (1; 2) 14 (12; 17) 71 (69; 74) 13 (11; 15)
Diet Pat (n=1,012) 1 (0; 2) 4 (3; 6) 22 (20; 25) 52 (49; 55) 20 (18; 23)
Phy (n=974) 0 (0; 1) 3 (2; 4) 14 (13; 17) 51 (48; 54) 32 (29; 35)
exercise Pat (n=1,012) 3 (2; 4) 6 (5; 7) 27 (25; 30) 46 (42; 49) 18 (16; 20)
Phy (n=974) 0 (0; 0) 4 (2; 5) 15 (12; 17) 51 (48; 54) 31 (28; 34)
Oral treatment Pat (n=1,012) 7 (5; 8) 3 (2; 4) 20 (17; 22) 49 (46; 53) 22 (19; 24)
Phy (n=974) 0 (0; 0) 0 (0; 0) 2 (1; 3) 62 (58; 65) 36 (33; 40)
injectable treatment Pat (n=1,012) 22 (19; 24) 3 (2; 4) 27 (24; 30) 33 (30; 36) 16 (14; 18)
Phy (n=974) 0 (0; 0) 1 (1; 2) 4 (3; 6) 57 (54; 61) 37 (34; 40)
Note: *P,0.001 in all comparisons.
Abbreviations: CI, confidence interval; Pat, patients; Phy, physicians; SMBG, self-management of blood glucose; T2DM, type 2 diabetes mellitus.
In general, patients perceived that they “frequently” 
or “always” followed physicians’ recommendations about 
routine SMBG, routine medical visits, diet, exercise, and 
oral treatments, while physicians’ answers indicated a 
lower frequency than patients’ opinions. As an example, 
almost a quarter of patients thought they “always” followed 
physicians’ diet (23%) and exercise recommendations 
(20%), while only 3% and 2% of physicians believed patients 
accomplished doctors’ suggestions regarding diet and exer-
cise, respectively. Regarding patients’ satisfaction with rou-
tine SMBG recommendations, the results showed that most 
patients were “satisfied” or “very satisfied” with them, while 
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the majority of physicians indicated that patients were “sat-
isfied” or “neither satisfied nor unsatisfied”. Interestingly, 
physicians perceived lower patient satisfaction with diet 
(5%) and exercise (4%) recommendations compared with 
the patients (17%) themselves. Concerning routine medical 
visits and oral and injectable treatment, the proportion of 
patients “satisfied” was lower than the patients satisfaction 
that physicians perceived.
On the other hand, although most patients and physicians 
reported that following medical recommendations allowed 
“quite a lot” of control of T2DM, the proportion was gener-
ally higher for physicians. Regarding patients’ perceptions 
about the importance of medical recommendations, most 
patients (57%) reported that it was “important”, while most 
physicians considered it as “very important” (58%).
Treatment
Thirty-nine percent of patients reported that physicians 
“always” take into account comorbidities when they choose 
a T2DM treatment, while doctors had a more favorable per-
ception, as 70% of them indicated the same assertion.
The majority of patients (53%) perceived that their cur-
rent T2DM treatment suited their preferences “quite a lot”, 
which was a lower proportion than among the physicians 
(69%). Additionally, fewer patients (53%) than physicians 
(79%) believed that their treatment improved their HRQoL 
“quite a lot”. Finally, 46% of physicians considered new 
technologies were very important for T2DM management, 
while only 29% of patients agreed with this statement.
Discussion
The findings in this study show that PC physicians and 
T2DM patients have different perceptions regarding their 
health status, PROs evaluation, and T2DM management and 
treatment in routine clinical practice in Spain.
The perceived health status of T2DM patients was worse 
compared with physicians’ opinions; nevertheless, physicians 
considered that T2DM had a higher impact on patients’ health 
statuses than the patients themselves. This fact is consistent 
with a previous study showing that health care profession-
als perceived T2DM as more serious and having a higher 
negative psychosocial impact than patients did.19 In addition, 
it has been shown that a poor understanding of the disease 
due to low health care quality may affect patients’ percep-
tions of seriousness, which consequently may influence 
self-management and treatment adherence;16,19 nevertheless, 
patients’ T2DM knowledge was not directly explored in this 
study and should be considered in future designs.
Regarding PROs, it should be noted that, despite patients 
and physicians considering PROs assessment important or 
very important, most patients perceived a low frequency of 
patient-centeredness in diabetes management and treatment 
compared with physicians’ opinions. In this sense, current 
guidelines10,13 recommend patient-centered care in which 
patients’ needs and preferences regarding treatment should 
be strongly considered by physicians for clinical decision 
making. Added to this, PROs assessment is increasingly being 
used in clinical trials and accepted as a measure of health and 
well-being in clinical practice.20 Nevertheless, results in this 
study show that the majority of physicians’ decisions related 
to diabetes management and treatment are not completely 
aligned with patients’ opinions and perspectives. On the 
other hand, it should be remarked that most patients in our 
study reported lower satisfaction and frequency regarding 
the information about T2DM, SMBG, and treatment admin-
istration techniques provided by the nurses compared with 
physicians’ perceptions. A good interaction between health 
care professionals (especially nurses) and patients has been 
shown to be paramount for appropriate patient-centered care15 
and is related to better disease understanding and patient 
self-management.16 In this regard, the majority of diabetes 
patients included in this study perceived that they followed 
medical recommendations regarding routine SMBG, routine 
medical visits, diet and exercise, and treatment to a greater 
degree than physicians thought they did.
Given the complexity of diabetes management, T2DM 
patients need to develop the competency to achieve disease 
control and improve their outcomes, which requires educa-
tion, a dietary intervention, exercise management, medica-
tion adjustment, and glucose monitoring.10 In the Spanish 
NHS, PC health care professionals, including nurses and 
physicians, are considered to have the main responsibility 
for providing information and recommendations to patients 
about the therapy and self-management of T2DM.21 It has 
been shown that self-management support interventions or 
programs are effective,22 but health care professionals report 
several limiting factors to providing better health care quality, 
such as lack of time and resources, inadequate training, or 
health system problems,21,23 that may influence the frequency 
and quality of education and information interventions.
The study has some limitations inherent to the observa-
tional design, including susceptibility to bias and confound-
ing, restricting the ability to define causality,24 and the lack of 
objective outcomes (such as glycemic control) which could 
allow describing of the patient population in more detail. 
Additional studies, including data from medical records, 
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such as glycemic control and weight variables, could reveal 
if diabetes could be treated well if patients gave less impor-
tance to its management. Moreover, it could be interesting to 
investigate further how patients’ diabetes durations can affect 
patients’ perceptions on diabetes management. In addition, in 
this study, professionals with at least 5 years’ post-residency 
experience were included, given that the authors wanted to 
reflect the perspectives of physicians with enough experi-
ence in the control of diabetic patients; however, it could 
be interesting to assess if physicians’ experience modifies 
their perceptions on diabetes management. Although the 
sample size was calculated to be representative of both sets 
of participants and the recruitment was performed with the 
support of independent and unbiased organizations (FEDE 
and RedGDPs), generalization of results should be performed 
with caution since participants might not represent the whole 
Spanish diabetes patient and PC physician population. Finally, 
considering that the administered questionnaire was not previ-
ously validated and that the included patients were from 47 
Spanish provinces and the physicians were from 52, the results 
must be interpreted with caution. The possibility that differ-
ent perceptions were due to misinterpretation of questions or 
because of the different perceptions were due to misinterpreta-
tion of questions or because of sociodemographics differences 
between patients and physicians cannot be ruled out.
Despite the described limitations, this study has several 
strengths, including the large sample of PC physicians and 
T2DM patients included, which provides relevant informa-
tion regarding perceptions and views in daily clinical practice 
of an heterogeneous patients’ and physicians’ population. 
These results are evidence of the need of modifying some 
components of the routine clinical practice in the NHS, 
such as understanding the patient and physician perspective 
and specifically incorporating greater patient-centeredness 
that may lead to the patients’ better understanding of the 
illness and consequently encourage better self-management 
behaviors.
Conclusion
The present study gives useful information about both phy-
sicians’ and T2DM patients’ views on PROs assessment, 
disease management, and treatment, providing useful insight 
into aspects that may influence medical decision making.
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